West Pharmaceutical Services stock has seen its fair value estimate rise from $321.45 to $350.77, as analysts respond to recent positive momentum. This upward adjustment reflects increased confidence ...

Supernus Pharmaceuticals (($SUPN)) has held its Q3 earnings call. Read on for the main highlights of the call. Supernus Pharmaceuticals’ recent ...

Recursion Pharmaceuticals, Inc (($RXRX)) has held its Q3 earnings call. Read on for the main highlights of the call. Recursion Pharmaceuticals, ...

Teva shares jumped 12% after Q3 earnings beat estimates, driven by strong branded drug sales led by Austedo and solid guidance for 2025.

Catalyst Pharmaceuticals (CPRX) shares have moved modestly in recent sessions, sparking fresh questions about its long-term value and growth prospects. Investors appear focused on underlying ...

Discover why ANIP may beat earnings estimates again, expand with new drug approvals, and raise 2025 guidance. Click here to ...

With strong returns on capital employed clubbed with high dividend yields, they are letting their investors know, they are in ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $33.5, a high estimate of $39.00, and a low estimate of $28.00. Marking an increase of 2.76%, the current ...

Vertex should earn other important approvals through 2030 that could jolt its stock price. It's developing a treatment called ...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the Stocks to Buy with Exponential Growth Heading into 2026.

Sun Pharmaceutical Industries , India's top drugmaker by revenue, reported quarterly profit above analysts' estimates on ...